ResMed, Inc. (RMD) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $230.65 +0.29%
Financial Fact:
Research and development: 34.45M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Research and development: 34.45M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
ResMed, Inc. (NYSE: RMD) reported Q3 EPS of $0.33, $0.02 worse than the analyst estimate of $0.35. Revenue for the quarter came in at $314.8 million versus the consensus estimate of $326.32 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor
- Deere shares climb as fiscal Q3 earnings and revenue top estimates
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
